CSPC Pharmaceutical Valuation

CHJTF Stock  USD 0.67  0.16  19.28%   
CSPC Pharmaceutical is overvalued. CSPC Pharmaceutical shows a prevailing Real Value of $0.6 per share. The current price of the firm is $0.67. Our model approximates the value of CSPC Pharmaceutical from analyzing the firm fundamentals such as profit margin of 0.19 %, and Return On Equity of 0.2 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.67
Please note that CSPC Pharmaceutical's price fluctuation is out of control at this time. Calculation of the real value of CSPC Pharmaceutical is based on 3 months time horizon. Increasing CSPC Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CSPC pink sheet is determined by what a typical buyer is willing to pay for full or partial control of CSPC Pharmaceutical Group. Since CSPC Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CSPC Pink Sheet. However, CSPC Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.67 Real  0.6 Hype  0.67 Naive  0.69
The real value of CSPC Pink Sheet, also known as its intrinsic value, is the underlying worth of CSPC Pharmaceutical Company, which is reflected in its stock price. It is based on CSPC Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CSPC Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.60
Real Value
8.36
Upside
Estimating the potential upside or downside of CSPC Pharmaceutical Group helps investors to forecast how CSPC pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CSPC Pharmaceutical more accurately as focusing exclusively on CSPC Pharmaceutical's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.670.670.67
Details
Hype
Prediction
LowEstimatedHigh
0.030.678.43
Details
Naive
Forecast
LowNext ValueHigh
0.010.698.45
Details

CSPC Pharmaceutical Total Value Analysis

CSPC Pharmaceutical Group is currently anticipated to have takeover price of 11.19 B with market capitalization of 13.6 B, debt of 682.56 M, and cash on hands of 13.97 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CSPC Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
11.19 B
13.6 B
682.56 M
13.97 B

CSPC Pharmaceutical Investor Information

About 30.0% of the company shares are held by company insiders. The book value of CSPC Pharmaceutical was currently reported as 2.35. The company has Price/Earnings To Growth (PEG) ratio of 2.55. CSPC Pharmaceutical last dividend was issued on the 8th of September 2022. The entity had 6:5 split on the 18th of June 2020. Based on the analysis of CSPC Pharmaceutical's profitability, liquidity, and operating efficiency, CSPC Pharmaceutical Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

CSPC Pharmaceutical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CSPC Pharmaceutical has an asset utilization ratio of 80.21 percent. This implies that the Company is making $0.8 for each dollar of assets. An increasing asset utilization means that CSPC Pharmaceutical Group is more efficient with each dollar of assets it utilizes for everyday operations.

CSPC Pharmaceutical Ownership Allocation

CSPC Pharmaceutical holds a total of 11.93 Billion outstanding shares. CSPC Pharmaceutical Group retains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

CSPC Pharmaceutical Profitability Analysis

The company reported the revenue of 27.87 B. Net Income was 5.61 B with profit before overhead, payroll, taxes, and interest of 21.14 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CSPC Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CSPC Pharmaceutical and how it compares across the competition.

About CSPC Pharmaceutical Valuation

The pink sheet valuation mechanism determines CSPC Pharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of CSPC Pharmaceutical. We calculate exposure to CSPC Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CSPC Pharmaceutical's related companies.
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. Cspc Pharmaceuticals operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 25147 people.

8 Steps to conduct CSPC Pharmaceutical's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CSPC Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CSPC Pharmaceutical's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain CSPC Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine CSPC Pharmaceutical's revenue streams: Identify CSPC Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research CSPC Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish CSPC Pharmaceutical's growth potential: Evaluate CSPC Pharmaceutical's management, business model, and growth potential.
  • Determine CSPC Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CSPC Pharmaceutical's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

CSPC Pharmaceutical Growth Indicators

Investing in growth stocks can be very risky. If the company such as CSPC Pharmaceutical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding11.9 B
Quarterly Earnings Growth Y O Y0.184
Forward Price Earnings14.4092
Retained Earnings19.2 B

Complementary Tools for CSPC Pink Sheet analysis

When running CSPC Pharmaceutical's price analysis, check to measure CSPC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSPC Pharmaceutical is operating at the current time. Most of CSPC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CSPC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSPC Pharmaceutical's price. Additionally, you may evaluate how the addition of CSPC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges